WallStreetZenWallStreetZen

NASDAQ: XBIT
Xbiotech Inc Stock

$6.58+0.02 (+0.3%)
Updated Jul 17, 2024
XBIT Price
$6.58
Fair Value Price
$6.57
Market Cap
$200.41M
52 Week Low
$3.51
52 Week High
$9.96
P/E
-6.45x
P/B
0.96x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$30.74M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.09
Operating Cash Flow
-$21M
Beta
0.84
Next Earnings
Aug 9, 2024
Ex-Dividend
N/A
Next Dividend
N/A

XBIT Overview

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how XBIT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

XBIT ($6.58) is overvalued by 0.13% relative to our estimate of its Fair Value price of $6.57 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
XBIT ($6.58) is not significantly undervalued (0.13%) relative to our estimate of its Fair Value price of $6.57 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
XBIT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more XBIT due diligence checks available for Premium users.

Be the first to know about important XBIT news, forecast changes, insider trades & much more!

XBIT News

Valuation

XBIT fair value

Fair Value of XBIT stock based on Discounted Cash Flow (DCF)
Price
$6.58
Fair Value
$6.57
Overvalued by
0.13%
XBIT ($6.58) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
XBIT ($6.58) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
XBIT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

XBIT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-6.45x
Industry
-21.17x
Market
30.24x

XBIT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.96x
Industry
6.35x
XBIT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

XBIT's financial health

Profit margin

Revenue
$0.0
Net Income
-$10.0M
Profit Margin
0%
XBIT's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$227.9M
Liabilities
$18.6M
Debt to equity
0.09
XBIT's short-term assets ($203.06M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
XBIT's short-term assets ($203.06M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
XBIT's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
XBIT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$7.2M
Investing
-$255.0k
Financing
$10.1M
XBIT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

XBIT vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
XBIT$200.41M+0.30%-6.45x0.96x
LCTX$200.13M-0.93%-8.15x2.76x
TRVI$200.04M-2.07%-8.35x2.77x
CHRS$199.62M-3.33%-2.38x-2.44x
ELYM$199.27M-2.97%-12.92x1.87x

Xbiotech Stock FAQ

What is Xbiotech's quote symbol?

(NASDAQ: XBIT) Xbiotech trades on the NASDAQ under the ticker symbol XBIT. Xbiotech stock quotes can also be displayed as NASDAQ: XBIT.

If you're new to stock investing, here's how to buy Xbiotech stock.

What is the 52 week high and low for Xbiotech (NASDAQ: XBIT)?

(NASDAQ: XBIT) Xbiotech's 52-week high was $9.96, and its 52-week low was $3.51. It is currently -33.94% from its 52-week high and 87.46% from its 52-week low.

How much is Xbiotech stock worth today?

(NASDAQ: XBIT) Xbiotech currently has 30,457,531 outstanding shares. With Xbiotech stock trading at $6.58 per share, the total value of Xbiotech stock (market capitalization) is $200.41M.

Xbiotech stock was originally listed at a price of $23.25 in Apr 15, 2015. If you had invested in Xbiotech stock at $23.25, your return over the last 9 years would have been -71.7%, for an annualized return of -13.09% (not including any dividends or dividend reinvestments).

How much is Xbiotech's stock price per share?

(NASDAQ: XBIT) Xbiotech stock price per share is $6.58 today (as of Jul 17, 2024).

What is Xbiotech's Market Cap?

(NASDAQ: XBIT) Xbiotech's market cap is $200.41M, as of Jul 18, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Xbiotech's market cap is calculated by multiplying XBIT's current stock price of $6.58 by XBIT's total outstanding shares of 30,457,531.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.